Group One Trading’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Group One Trading’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,000	Closed	-$173K	–	5528
2015 Q3	$173K	Sell	4,000 -14,400	-78%	-$608K	﹤0.01%	2615
2015 Q2	$778K	Buy	+18,400	New	+$776K	0.01%	1421
2015 Q1	–	Sell	-2,500	Closed	-$84K	–	5604
2014 Q4	$84K	Buy	2,500 +500	+25%	+$17.7K	﹤0.01%	2988
2014 Q3	$70K	Buy	2,000 +1,700	+567%	+$58.3K	﹤0.01%	3302
2014 Q2	$10K	Buy	+300	New	+$10.3K	﹤0.01%	4535
2013 Q4	–	Sell	-200	Closed	-$5K	–	5826
2013 Q3	$5K	Buy	+200	New	+$4.74K	﹤0.01%	4782

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Group One Trading's WX Position: Q4 2015 in Review

Group One Trading sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 59,159 shares — an estimated $2.56M sold.

Group One Trading first reported a position in WX in Q2 2015 and held it in 2 quarters. The position peaked at $2.56M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Group One Trading reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Group One Trading sold 59,159 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $2.56M.
Group One Trading first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 2 quarters.
Group One Trading's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $2.56M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Group One Trading's 13F filing for Q4 2015, filed 11 Feb 2016.